Induction of NTPDase1/CD39 by Reactive Microglia and Macrophages Is Associated With the Functional State During EAE. by Jakovljević, Marija et al.
fnins-13-00410 April 25, 2019 Time: 16:15 # 1
ORIGINAL RESEARCH
published: 26 April 2019
doi: 10.3389/fnins.2019.00410
Edited by:
Cintia Roodveldt,
Centro Andaluz de Biología Molecular
y Medicina Regenerativa (CABIMER),
Spain
Reviewed by:
Markus Kipp,
Munich Cluster for Systems
Neurology, Germany
Antje Kroner,
Medical College of Wisconsin,
United States
*Correspondence:
Danijela Laketa
danijela@bio.bg.ac.rs
Specialty section:
This article was submitted to
Neurodegeneration,
a section of the journal
Frontiers in Neuroscience
Received: 23 January 2019
Accepted: 10 April 2019
Published: 26 April 2019
Citation:
Jakovljevic M, Lavrnja I, Bozic I,
Milosevic A, Bjelobaba I, Savic D,
Sévigny J, Pekovic S, Nedeljkovic N
and Laketa D (2019) Induction
of NTPDase1/CD39 by Reactive
Microglia and Macrophages Is
Associated With the Functional State
During EAE. Front. Neurosci. 13:410.
doi: 10.3389/fnins.2019.00410
Induction of NTPDase1/CD39 by
Reactive Microglia and Macrophages
Is Associated With the Functional
State During EAE
Marija Jakovljevic1, Irena Lavrnja1, Iva Bozic1, Ana Milosevic1, Ivana Bjelobaba1,
Danijela Savic1, Jean Sévigny2,3, Sanja Pekovic1, Nadezda Nedeljkovic4 and
Danijela Laketa4*
1 Department of Neurobiology, Institute for Biological Research “Siniša Stankovic´”, University of Belgrade, Belgrade, Serbia,
2 Département de Microbiologie-Infectiologie et d’Immunologie, Faculté de Médecine, Université Laval, Quebec City, QC,
Canada, 3 Centre de Recherche du CHU de Québec, Université Laval, Quebec City, QC, Canada, 4 Department for General
Physiology and Biophysics, Faculty of Biology, University of Belgrade, Belgrade, Serbia
Purinergic signaling is critically involved in neuroinflammation associated with multiple
sclerosis (MS) and its major inflammatory animal model, experimental autoimmune
encephalomyelitis (EAE). Herein, we explored the expression of ectonucleoside
triphosphate diphosphohydrolase1 (NTPDase1/CD39) in the spinal cord, at the onset
(Eo), peak (Ep), and end (Ee) of EAE. Several-fold increase in mRNA and in
NTPDase1 protein levels were observed at Eo and Ep. In situ hybridization combined
with fluorescent immunohistochemistry showed that reactive microglia and infiltrated
mononuclear cells mostly accounted for the observed increase. Colocalization analysis
revealed that up to 80% of Iba1 immunoreactivity and ∼50% of CD68 immunoreactivity
was colocalized with NTPDase1, while flow cytometric analysis revealed that ∼70%
of mononuclear infiltrates were NTPDase1+ at Ep. Given the main role of NTPDase1
to degrade proinflammatory ATP, we hypothesized that the observed up-regulation
of NTPDase1 may be associated with the transition between proinflammatory M1-
like to neuroprotective M2-like phenotype of microglia/macrophages during EAE.
Functional phenotype of reactive microglia/macrophages that overexpress NTPDase1
was assessed by multi-image colocalization analysis using iNOS and Arg1 as selective
markers for M1 and M2 reactive states, respectively. At the peak of EAE NTPDase1
immunoreactivity showed much higher co-occurrence with Arg1 immunoreactivity in
microglia and macrophages, compared to iNOS, implying its stronger association with
M2-like reactive phenotype. Additionally, in∼80% of CD68 positive cells NTPDase1 was
coexpressed with Arg1 compared to negligible fraction coexpresing iNOS and ∼15%
coexpresing both markers, additionally indicating prevalent association of NTPDase1
with M2-like microglial/macrophages phenotype at Ep. Together, our data suggest
an association between NTPDase1 up-regulation by reactive microglia and infiltrated
macrophages and their transition toward antiinflammatory phenotype in EAE.
Keywords: NTPDase1/CD39, EAE, ATP, neuroinflammation, microglia/macrophages, astrocytes
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INTRODUCTION
Multiple sclerosis (MS) is a chronic autoimmune disease of
the central nervous system (CNS), characterized by focal
neurodegenerative and demyelinating lesions (Lassmann,
2018). The disease-associated tissue injury is the consequence
of neuroinflammation, conducted by CNS resident reactive
microglia and astrocytes, and infiltrated cells, mainly Th1, Th17
and monocytes/macrophages (Lassmann, 2014). Although MS
is a uniquely human disease and despite different levels of
similarities with various models of experimental autoimmune
encephalomyelitis (EAE) (Behan and Chaudhuri, 2014) EAE is
still the only model reflecting range of pathological and clinical
features of MS (Van Der Star et al., 2012; Baker and Amor,
2014). The accumulated data obtained in EAE model, point
to microglia/macrophages and astrocytes as critical players in
neuroinflammation associated with MS/EAE (Mensah-Brown
et al., 2011; Bjelobaba et al., 2018).
Although the causative factors of the autoimmune response
in MS are not entirely known, it is considered that the
pathological trigger in EAE are self-reactive CD4+ Th1
and Th17 cells, which enter the CNS, where they become
reactivated by resident phagocytes (Miljkovic et al., 2011),
initiating inflammatory reaction and inducing microglial
and astrocytic activation. Reactive microglia and astrocytes
propel neuroinflammation that results in demyelination, cell
loss and axonal damage (Murphy et al., 2010; Brambilla
et al., 2014). In MS, the subsequent cross-talk between
reactive microglia/macrophages and activated astrocytes
usually leads to self-sustained chronic neuroinflammation and
progressive/irreversible neurodegeneration (Brosnan and Raine,
2013; Lassmann, 2018), whereas in the acute EAE models,
the full-blown neuroinflammation turns into resolution, with
ensuing myelin repair and tissue recovery. The accumulated data
show that the course of the pathogenic event, chronic vs. acute,
depends above all, on the functional state of activated microglia
and astrocytes (Brosnan and Raine, 2013; Cherry et al., 2014).
As resident macrophages in the CNS, ramified microglia are
constantly engaged in surveillance of the microenvironment,
searching for signs of tissue or metabolic damage (Hanisch
and Kettenmann, 2007). When they encounter harmful stimuli,
microglia rapidly respond by upregulating MHC class II
and co-stimulatory molecules (Becher et al., 2006), and by
enhancing the production of cytokines, chemokines, reactive
oxygen and nitrogen species, accompanied with shortening and
thickening of processes and adoption of amoeboid morphology
(Saijo and Glass, 2011). Specific cytokine milieu may polarize
microglia and macrophages toward one end of the spectrum
of continuous phenotypes, termed M1 and M2 (Mosser and
Edwards, 2008; Cherry et al., 2014) (but see also Ransohoff,
2016). The two extreme phenotypes were characterized in vitro,
with M1 proinflammatory phenotype induced by “classical”
activation using proinflammatory factors such as IFNγ and LPS
and “alternatively” activated M2 antiinflammatory phenotype,
obtained after IL-4 or IL-13 exposure (Saijo and Glass,
2011). In vivo, activated microglia and macrophages usually
acquire intermediate, overlapping phenotypes between these
two extreme activation states, with functions depending on
combination of M1/M2 polarization markers (Fumagalli et al.,
2015; Lan et al., 2017). Although M1 and M2 phenotypes
were observed only in vitro, M1/M2 classification is useful in
understanding functions of microglia/macrophages in various
CNS pathologies (Hu et al., 2015). Namely, in mouse model
of spinal cord injury, despite global rise in both type of
markers, majority of microglia and macrophages developed M1
phenotype (Kroner et al., 2014). In model of stroke, transition
from M2 microglia/macrophages to M1 phenotype was reported
(Hu et al., 2012), whereas in MS and in an animal model
of epilepsy, mixed M1/M2 phenotypes were detected (Vogel
et al., 2013; Benson et al., 2015; Fumagalli et al., 2015).
The pathogenic context and/or dominant activated microglial
phenotype further drive activation of astrocytes. Activated
astrocytes may polarize toward one of two functional states,
termed A1 and A2 (Liddelow et al., 2017). A1 astrocytes up-
regulate gene expression of complement component 3 (C3)
and proinflammatory cytokines, that determine their neurotoxic
phenotype, while A2 astrocytes up-regulate gene expression of
many neurotrophic factors and antiinflammatory cytokines, that
determine their neuroprotective phenotype (Zamanian et al.,
2012). Therefore, prevailing functional phenotypes of activated
microglia and astrocytes determine the nature and course of
neuroinflammation (Pekny et al., 2016; Tang and Le, 2016).
Neuroinflammation begins with the emergence of danger
signals, which may be pathogen- or danger – associated
molecular patterns. Much evidence has been collected showing
that extracellular adenosine triphosphate (ATP), released in
high concentrations from damaged or dying neurons acts
as danger-associated molecular pattern (Di Virgilio et al.,
2009). This nucleotide acts at a subset of P2 receptor subtypes
expressed at resident cells (microglia and astrocytes), and
infiltrating immune cells, to initiate the inflammatory response
(Di Virgilio et al., 2009). The P2 receptor family comprises
the P2X1-7, which are ATP-gated ion channels, and P2Y1−14,
which belong to G-protein coupled receptors, activated by
tri- and diphosphonucleotides, including ATP, UTP, ADP and
UDP (Abbracchio et al., 2009). Upon release, extracellular
ATP is catabolized by ectonucleotidase enzymes, that catalyze
the sequential hydrolysis of ATP to adenosine. Ectonucleoside
triphosphate diphosphohydrolases-1 and -2 (NTPDase1 and
NTPDase2) and ecto-5′-nucleotidase (e-5NT/CD73), which
are most abundantly expressed by the glial cells (Braun et al.,
2000, 2003; Brisevac et al., 2015) are capable to complete
degradation of extracellular ATP to adenosine (Yegutkin, 2008).
However, each step of the nucleotide hydrolysis generates a
ligand for a distinct purinergic receptor subtype (Yegutkin,
2014). NTPDase1, also known as CD39, hydrolyzes ATP and
ADP equally well, thus efficiently clearing the P2 receptor
ligands from the extracellular space (Kukulski and Komoszynski,
2003). In rodent brain, NTPDase1 is constitutively expressed by
microglia, endothelial and smooth muscle cells of the vasculature
(Braun et al., 2000), thus being involved in microglial activation
(Farber and Kettenmann, 2006), regulation of blood-brain
barrier function (Bynoe et al., 2015), and control of cerebral
blood flow (Sevigny et al., 2002). On the other hand, NTPDase2,
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mostly associated with white matter astrocytes and neural
progenitors (Braun et al., 2003; Jakovljevic et al., 2017), produces
a ligand for ADP-sensitive P2Y1, P2Y12, and P2Y13 receptors
present at astrocytes, microglial cells, oligodendrocytes and
neurons (Abbracchio et al., 2009; Pérez-Sen et al., 2015). Finally,
e-5NT/CD73, abundantly expressed by astrocytes, vascular
endothelium, and choroid plexus epithelium (Jacobson and
Gao, 2006; Mills et al., 2008; Lavrnja et al., 2015), generates
adenosine (Zimmermann, 1992) which activates G-protein
coupled adenosine receptor subtypes, A1, A2A, A2B, and A3
(Fredholm et al., 2011). It is of special note, that in contrast
to ATP, which induces an inflammatory response, adenosine
acts as a potent antiinflammatory and immunosuppressive
factor (Di Virgilio and Vuerich, 2015). Microglia and astrocytes
are well-equipped with all subtypes of purinergic receptors,
and they have a central role in their dynamic modal shifts
during neuroinflammation (Abbracchio and Ceruti, 2006;
Koizumi et al., 2013).
A number of studies proved critical involvement of purinergic
signaling in neuroinflammation associated with MS/EAE.
Specifically, it has been demonstrated that e-5NT and
A2A receptor-mediated signaling are required for leukocyte
transmigration through vascular endothelium or choroid plexus
epithelium for efficient induction of EAE (Mills et al., 2012).
It was also shown that NTPDase1/CD39 is essential for
immunoregulatory function of specific Tregs subset of CD4+
T cells, which attenuate neuroinflammation during EAE
(Wang et al., 2014). Expression of NTPDase1 in dendritic
cells supress EAE development through decreasing Th1 and
Th17 activation, while vaccination with IL-27 treated dendritic
cells reduce severity of chronic EAE due to their induction of
NTPDase1 (Mascanfroni et al., 2013). Dynamic alterations in
the activity of the whole ectonucleotidase enzyme chain have
been reported in EAE (Lavrnja et al., 2009), due to significant
induction of e-5NT and down-regulation of NTPDase2 at
mRNA and protein level, mostly by reactive astrocytes in the
spinal cord of affected animals (Lavrnja et al., 2015; Jakovljevic
et al., 2017). Significant induction of NTPDase1 protein has
been demonstrated in EAE (Jakovljevic et al., 2017) and
traumatic brain injury model, where it was upregulated by
reactive microglia (Nedeljkovic et al., 2006). On the other hand,
induction of NTPDase1 and e-5NT was shown in vitro in IL-4
stimulated macrophages exhibiting M2 phenotype (Zanin et al.,
2012). Given the main function of NTPDase1 is to hydrolyze
ATP and ADP, thereby providing the substrate for e-5NT
and generation of adenosine, it is likely that the induction
of NTPDase1 by reactive microglia/macrophages may be a
part of the program that guides the development of M2-like
microglial/macrophages phenotype and consequent induction
of neuroprotective astrocyte phenotype (Shinozaki et al., 2017).
Therefore, in the present study, we have analyzed the induction
of NTPDase1 during EAE and identified microglia/macrophages
as major cell types responsible for the induction. Since
microglia and macrophages may polarize toward M1 or M2
reactive phenotypes, we have further established a potential
association between NTPDase1 induction and polarization of
microglia/macrophages to neuroprotective M2-like phenotype.
MATERIALS AND METHODS
Experimental Autoimmune
Encephalomyelitis and Disease Score
Assessment
Eight-week old female rats of Dark Agouti (DA) inbred strain (48
animals) from the local colony were used for the experiments.
Experimental protocols were approved by the Ethical Committee
for the Use of Laboratory Animals of the Institute of Biological
Research “Siniša Stankovic´,” Belgrade, Serbia (Application No.01-
11/14) and in compliance with the ECC Directive (2010/63/EU)
on the protection of animals used for experimental and other
scientific purposes. Littermate animals were housed 2–5 per
cage under conventional conditions: constant temperature and
humidity, 12 h light/dark cycle, and laboratory chow and
water ad libitum. Paralyzed animals were fed and given water
manually. Animals were immunized on the same day (36
animals). Immunization was performed under anesthesia in
the hind footpad by a subcutaneous injection of 150 µl of
encephalitogenic emulsion of rat spinal cord homogenate (50%
w/v in saline) mixed with an equal volume of complete Freund’s
adjuvant containing 1 mg/mL Mycobacterium tuberculosis (CFA;
Sigma, St. Louis, MO, United States). Age-matched animals (12
animals) were anesthetized without subsequent immunization
and used as an intact physiological control. All the animals were
weighed and monitored daily for the clinical signs of EAE up
to 30 days post immunization. Disease severity was assessed
by standard 0–5 EAE grading scale as follows: 0 – unaffected;
0.5 – reduced tail tone; 1 – tail atony; 1.5 – slightly/moderately
clumsy gait, impaired righting ability or combination; 2 – hind
limb paresis; 2.5 – partial hind limb paralysis; 3 – complete hind
limb paralysis; 3.5 – complete hind limb paralysis with fore limb
weakness; 4 – moribund state and 5 –death of the animal. Scores
obtained by blind scoring were averaged and plotted as daily
mean clinical score.
Tissue Preparation
The animals were euthanized at three time points representing
three phases of the acute monophasic disease – onset (Eo),
peak (Ep), and end of symptoms (Ee). Under deep anesthesia
with Zoletil R© 50 (Virbac, France; 30 mg/kg i.p.), animals
were perfused with 0.9% sodium chloride and decapitated.
Following decapitation, lumbosacral spinal cords were isolated
and prepared for RNA isolation, Western blot, Flow Cytometry
or cryosectioning.
Real-Time PCR
Lumbosacral part of spinal cord (3/group) was cut and used
for RNA isolation with TRIzol R© reagent (Invitrogen, Carlsbad,
CA, United States) according to manufacturer’s instructions.
RNA concentrations were measured using spectrophotometer
and RNA purity was determined by measurement of A260/A280
and A260/A230 ratios. A volume equivalent to 1 µg of RNA
was used for reverse transcription with High Capacity cDNA
Reverse transcription kit (Applied Biosystems, Foster City, CA,
United States). cDNA was then diluted 10 times and these
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probes were used for real-time PCR standard protocol described
previously (Jakovljevic et al., 2017) with QuantStudioTM 3
Real-Time PCR System (Applied Biosystems, Foster City, CA,
United States). For negative control, cDNA template was omitted
from PCR mixture. Relative expression of target gene was
determined by 2−11Ct method, with Gapdh (glyceraldehide-
3-phosphate dehydrogenase) as reference gene (Lavrnja et al.,
2015). Quality control was routinely performed by melting
curve analysis and gel electrophoresis of obtained PCR products.
Primer sequences are listed in Table 1.
Isolation of Crude Plasmamembrane
Fraction
Lumbosacral spinal cord parts for each group (3/group) were
pooled and further processed to obtain crude plasmamembrane
preparation (Gray and Whittaker, 1962). After homogenization
in 5 mmol/L Tris, pH 7.4 buffer containing 320 mmol/L sucrose,
the homogenates were centrifuged at 3.000 × g for 10 min at
4◦C. Supernatant was taken and further centrifuged at 12.000× g
for 40 min at 4◦C. Then, the obtained pellets were resuspended
in 5 mmol/L Tris pH 7.4 and used for Western blot, after
determination of protein concentration using Micro BCA Protein
Assay Kit (Thermo Fisher Scientific, Rockford, IL, United States).
Western Blot
Crude plasma membrane samples were diluted in 4 × Laemmli
Sample Buffer (#161-0747 Bio-Rad, Hercules, CA, United States)
and incubated for 5 min at 95◦C. After cooling on ice,
sample proteins (15 µg per lane) were loaded on a 7.5%
PAGE-SDS gels in non-reducing conditions and the resolved
proteins were electrotransferred to a support membrane
(Immobilon-P transfer membrane, Millipore, Darmstadt,
Germany). After transfer, membranes were blocked in
5% Bovine Serum Albumine (BSA, Sigma, St. Louis, MO,
United States) in Tris-buffer saline Tween-20 (TBST) and
probed with anti-NTPDase1 primary antibodies indicated in
Table 2, at 4◦C overnight. After triple washing in TBST for
10 min, the membranes were incubated in anti-guinea pig
secondary HRP-conjugated IgG antibodies indicated in Table 2,
2 h/room temperature. X-ray films (Kodak, Rochester, NY,
United States) were used for visualization of chemiluminescent
signal (ECL, GE Healthcare, United States). Densitometric
analysis using ImageJ software package (RRID:SCR_003070)
TABLE 1 | Primer sequences.
Target
gene
Forward Reverse
Gapdh TGGACCTCATGGCCTACAT GGATGGAATTGTGAGGGAGA
Entpd1 TCAAGGACCCGTGCTTTTAC TCTGGTGGCACTGTTCGTAG
Aif1 CCAGCGTCTGAGGAGCTATG CGTCTTGAAGGCCTCCAGTT
Itgam GACTCCGCATTTGCCCTACT TGCCCACAATGAGTGGTACAG
Cx3cr1 TTCTTCCTCTTCTGGACGCCT TGAGGCAGCAGTGGCTAAAC
Nos2 CAGCCCTCAGAGTACAACGAT CAGCAGGCACACGCAATGAT
Arg1 TAACCTTGGCTTGCTTCGG GTGGCGCATTCACAGTCAC
Cd68 TGTGTGTCTGACCTTGCTGG AAGGATGGCAGAAGAGTGGC
was performed to determine optical density of protein
bands. Optical density of β-actin bands in the same lane
was used for normalization and resulting values obtained
from 5 separate membranes were expressed relative to control
(100%)± SEM.
Flow Cytometry
Lumbosacral parts of spinal cords (3/group) were homogenized
through nylon sieve and centrifuged at 800 × g for 3 min. Pellet
was resuspended in 30% Percoll (Sigma-Aldrich, United States),
transferred gently to a tube filled with 70% Percoll and
centrifuged at 870 × g for 50 min at room temperature.
Mononuclear infiltrate cell layer was transferred and resuspended
in PBS and centrifuged again at 900 × g for 10 min. Pellet
was re-suspended in PBS, cells were counted and 106 cells
were used for subsequent labeling and flow cytometric analysis.
Cells were again centrifuged at 3000 × g for 4 min, re-
suspended in PBS with 10% normal rat serum and incubated
with primary antibodies (Table 2) for 45 min at 4◦C.
Cells were washed three-times in PBS and then incubated
with fluorescently labeled secondary antibody, where primary
antibody was unlabeled (Table 2). After triple washing step in
PBS, flow cytometric analysis was performed on CyFlow R© Space
Partec (Partec GmbH, Munster, Germany), and the software
used for data analysis was PartecFloMax R© (Partec GmbH,
Munster, Germany).
Immunohistochemistry and
Immunofluorescence
Transverse cryosections of the lumbar spinal cord (20 µm
thickness) (3 animals/group) were incubated at room
temperature for 30 min for acclimatization prior to triple washing
step in PBS in duration of 5 min. For immunohistochemistry,
sections were subsequently incubated in 0.3% hydrogen peroxide
in methanol for blocking the endogenous peroxidase. Sections
were then incubated for 1 h in blocking solution containing
either 1% BSA or Normal Donkey Serum (10% in PBS;
Santa Cruz Biotechnology, Santa Cruz, CA, United States),
followed by overnight incubation with primary antibodies
to various CNS cell type specific markers (Table 2) at
4◦C in a humid chamber. After the first primary antibody
incubation and subsequent triple PBS washing step, the
sections were incubated with secondary antibody linked with
horseradish peroxidase (HRP) for immunohistochemistry
or fluorescent label for immunofluorescence, respectively
(Table 2), for 2 h at room temperature in a humid
chamber in the dark and washed three times in PBS. In
immunohistochemistry method, specific antigen – antibody
reaction was visualized by brief incubation of sections with
3,3′S-diaminobenzidine-tetrahydrochloride (DAB, Dako,
Glostrup, Denmark). Reaction was stopped by washing
in tap water, followed by 5 min incubation of sections in
70, 96, 100% ethanol and twice in xylene, respectively for
dehydration. Sections were mounted with DPX Mounting
medium (Fluka, Buchs, Switzerland) and examined under
a Zeiss Axiovert microscope (Carl Zeiss GmbH, Vienna,
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TABLE 2 | List of antibodies.
Antibody Source and type Dilution Manufacturer
NTPDase1 mN1-2C(I4,I5) Guineapig, polyclonal 1:200 (IF)a
1:6000 (WB)b
1:400 (FACS)c
Ectonucleotidases-ab.com;Cat# NTPDase1
GFAP Mouse, monoclonal 1:500 (IF)
1:200 (IHC)d
UC Davis/NIH NeuroMab Facility (73–240),
RRID:AB_10672298ED1
Iba1 Goat, polyclonal 1:400 Abcam ab5076, RRID:AB_2224402
CD68/ ED1 Mouse, monoclonal 1:100 Abcam ab31630, RRID:AB_1141557
iNOS Rabbit, polyclonal 1:200 Abcam ab15323, RRID:AB_301857
Arg-1 Rabbit, polyclonal 1:200 Sigma AV45673, RRID:AB_1844986
Glutamine synthetase Rabbit, polyclonal 1:1000 Abcam ab49873, RRID:AB_880241
Vimentin Mouse, monoclonal 1:200 Dako M0725 RRID:AB_10013485
COX-2 Goat, polyclonal 1:50 Santa Cruz sc-1745, RRID:AB_631309
C3 Goat, polyclonal 1:500 Thermo Fisher Scientific PA1-29715
RRID:AB_AB_2066730
NF-H/SMI32 Mouse, monoclonal 1:2000 Covance Research Products Inc
AB_509997, RRID:AB_509997
CD4 Mouse, monoclonal 1:100 Sigma-Aldrich SAB4700733,
RRID:AB_476825733
CD40 Rabbit, polyclonal 1:100 Abcam ab65853 RRID:AB_1141079
CD45 Mouse, monoclonal Conjugated to PE 1:10 Bio-Rad MCA43PE RRID:AB_321412
P2Y1 Rabbit, polyclonal 1:200 Alomone Labs; #APR-0009,
RRID:AB_2040070
Anti-mouse IgG Alexa Fluor 488 Donkey, polyclonal 1:250 Invitrogen A21202 RRID:AB_141607
Anti – guinea pig IgG Alexa Fluor 555 Goat, polyclonal 1:250 Invitrogen A-21435 RRID:AB_2535856
Anti – guinea pig IgG Alexa Fluor 488 Goat, polyclonal 1:200 (FACS) Invitrogen A-11073 RRID: AB_2534117
Anti-goat IgG Alexa Fluor 488 Donkey, polyclonal 1:250 Invitrogen A-11055 RRID:AB_142672
Anti-rabbit IgG Alexa Fluor 488 Donkey, polyclonal 1:250 Invitrogen A-21206, RRID:AB_141708
Anti-mouse IgG Alexa Fluor 350 Donkey, polyclonal 1:250 Invitrogen A10035 RRID:AB_2534011
Anti-goat IgG Alexa Fluor 350 Donkey, polyclonal 1:250 Invitrogen A-21081 RRID:AB_2535738
Anti-mouse HRP conjugated IgG Donkey, polyclonal 1:250 Santa Cruz sc-2314, RRID:AB_641170
Anti-rabbit HRP conjugated IgG Donkey, polyclonal 1:250 Santa Cruz sc-2313 RRID:AB_641181
a IF, immunofluorescence; bWB, western blot; cFACS, flow cytometry; d IHC, immunohistochemistry.
Austria). For double and triple immunofluorescence, blocking
and overnight primary antibody incubation steps were
repeated. Nuclei were counterstained with Hoechst 33342
dye (5 µg/ml – Life Technologies, Invitrogen, Carlsbad, CA,
United States) for 10 min at room temperature and washed
in PBS to minimize the background. Sections incubated
without primary antibody were used as negative controls.
Microscopic slides with cryosections for immunofluorescence
were mounted in Mowiol (Calbiochem, Millipore, Germany)
and captured on Zeiss Axiovert fluorescent microscope
(Zeiss, Jena, Germany).
Quantification of Immunofluorescence
and Multi-Image Colocalization Analysis
Image analyses were conducted using ImageJ open-source
platform1 (RRID:SCR_003070). The number of infiltrates
per spinal cord cross section and the number of cells per
infiltrate were counted manually from n ≥ 6 sections per
spinal cord, from 3 animals per disease phase, from two
separate EAE experiments. Raw immunofluorescent micrographs
1http://imagej.nih.gov/ij/download.html
taken under the same conditions were used to measure
integrated fluorescence density and the density confined within
five pre-defined regions of interest (ROIs), with background
fluorescence subtraction for at least 3 images per ROI
and n ≥ 6 sections per spinal cord, from 3 animals per
experimental time point. The ROI were dorsal gray matter,
ventral gray matter, dorsal white matter, ventral white matter,
and lateral white matter. Fluorescence intensity corresponding
to NTPDase1 of α-motoneuronal somata was determined
as density confined within ROI, determined as an outline
of motor neuron bodies, from at least 3 ROI per section,
for n ≥ 6 sections per spinal cord, from 3 animals per
experimental time point. Multi-image colocalization analysis
was performed in the whole section, both in the white and
gray matter, using JACoP ImageJ plugin. A degree of overlap
and correlation between multiple channels was estimated by
calculating Pearson’s correlation coefficient (PCC) and Manders’
colocalization coefficient (MCC) (Dunn et al., 2011). PCC is
statistical parameter that reflects both co-occurrence (degree
at which intensities of two channels for each pixel are
beyond or above the threshold), and correlation (pixel-for-
pixel proportionality in the signal levels of the two channels).
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MCC is sensitive just to co-occurrence and it measures the
fraction of pixels with positive values for both channels,
regardless of the signal intensities. When determining the
fractional overlap between two signals, signal 1 and signal
2, two different MCC values were derived. MCC1 reflects
the fraction of signal 1 that co-localizes with signal 2,
while MCC2 represents the fraction of signal 2 that co-
localizes with signal 1.
In situ Hybridization
Cryosections of the lumbosacral spinal cord were incubated
with 15 µg /ml Proteinase K solution (Invitrogen, Carlsbad,
CA, United States) in a buffer containing 5 mmol/L Tris-HCl,
1 mmol/L EDTA and 1 mmol/L NaCl in diethyl-pyrocarbonate
(DEPC; Sigma, St. Louis, MO, United States) treated water
at 37◦C for 20 min in a humid chamber prior to PBS
washing step and brief dehydration in a series of ethanol
solutions with ascending concentrations. After dying,
sections were covered with in situ hybridization buffer
(50% formamide, 20% 20x Saline Sodium Citrate Buffer –
SSC, 5% Phosphate Buffer and 10 µg/ml Deoxyribonucleic
acid from herring sperm – Sigma, St. Louis, United States)
containing 1000 pg/µl of digoxigenin (DIG) – labeled NTPDase1
oligonucleotide probe and incubated overnight in humid
chamber at 42◦C. The sequence of NTPDase1 oligonucleotide
probe was GCTGGATGCCGGGTCGTCTCACA
CCAACCTGTACATCTAC. The probe was labeled with
DIG Oligonucleotide 3′ – End Labeling Kit, 2nd Generation
(# 03 353 575 910, Roche, Basel, Switzerland) according to
manufacturer’s instructions. Negative controls contained no
probe in hybridization buffer. On the following day the sections
were washed in 5×, 1×, and 0.2× SSC buffer (3 mol/L NaCl,
0.3 mol/L Na-citrate, pH 7), twice at 42◦C and once in PBS at
room temperature. Blocking step consisted of incubation in
blocking buffer with final concentration of 0.01% Fetal Calf
Serum (FCS, Invitrogen, Carlsbad, CA, United States) and
BSA at room temperature for 20 min. The sections were then
incubated with Anti–DIG Alkaline Phosphatase conjugated
antibody (1:200, #011093274910, Roche, Basel, Switzerland) for
2 h at room temperature and washed in 0.1% Tween-20 in PBS.
Visualization step was done with NBT/BCIP (#011697471001,
Roche, Basel, Switzerland) according to manufacturer’s
instruction with 0.2 µmol/L levamisole (Sigma, St. Louis,
MO, United States). Slides with spinal cord sections were then
used for HRP – based immunohistohemical counterstaining
of GFAP. All reagents for in situ hybridization were made in
DEPC-treated water and sterilized.
Data Analysis
Data homogeneity was tested using Levene’s test (SPSS 20, IBM,
Armonk, NY, United States). Statistical analysis was performed
in GraphPad Prism 5 Software R© (GraphPad Software, La Jolla,
CA, United States) using Kruskal – Wallis test followed by
Dunn’s post hoc test or one-way analysis of variance (ANOVA)
followed by Dunnett post hoc test, as apropriate. The data were
presented as Mean± SEM and considered statistically significant
for p< 0.05.
RESULTS
Disease Score During EAE
The disease initiated by immunization with the encephalitogenic
emulsion exhibited acute monophasic course in all animals
(Figure 1). The severity of the disease at each day post-induction
(dpi) was expressed as mean disease score that was calculated
using arbitrary 1–5 disease scale. The daily mean disease score
which reflected the severity of symptoms, began to increase from
10 dpi (Eo), peaked at 15 dpi (Ep) and thereafter gradually
decreased and ended at 30 dpi (Ee). Changes in animal body
weight mirrored the disease score, showing maximum weight loss
at the peak of the disease.
Expression of NTPDase1 During EAE
The expression profile of NTPDase1 at mRNA (Entpd1) and
protein level in the lumbar spinal cord in control and EAE
animals are presented in Figures 2A–C. Both mRNA and
protein expression gradually increased during EAE, with most
pronounced induction at Ep. At mRNA level, NTPDase1
expression increased two-fold at Eo and three-fold at Ep while
protein expression increased two-fold at Ep. At the end of
the disease, both mRNA and protein abundance returned to
the control levels.
Expression of NTPDase1 in spinal cord cross sections was
visualized by fluorescence immunohistochemistry (Figure 2D),
using well-characterized antibodies directed to NTPDase1 (mN1-
2C) (Martin-Satue et al., 2009). In control sections under low
magnification, the most intensive NTPDase1 immunoreactivity
was associated with the pial surface, numerous small ramified
cells in the gray matter and elongated fibrous elements which
traverse the white matter. The overall fluorescence intensity
FIGURE 1 | Disease score. Animals were weighed and scored daily for
neurological signs of EAE using standard 0–5 EAE grading scale. Plots
represent daily mean disease score ± SEM (violet triangles) and mean body
mass (gray circles) during EAE, measured in two separate rounds of EAE
inductions. Arrows point to days 10, 15, and 30 post-immunization, which
correspond to the onset of disease (Eo), the peak of neurological symptoms
(Ep) and the end of disease (Ee).
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FIGURE 2 | Expression analysis of NTPDase1 during EAE. (A) Transcriptional expression of Entpd1 in spinal cord tissue homogenate. Bars represent mean
NTPDase1/GAPDH-mRNA abundance (±SEM), determined in total RNA isolated from the lumbar spinal cord of control rats (100%) and rats at Eo, Ep, and Ee.
Samples were collected from three animals per group, from two separate experiments. ∗p < 0.05, ∗∗p < 0.001. (B) Western blot analysis of NTPDase1 in crude
plasma membranes isolated from spinal cord tissue. The intensities of protein bands were assessed by densitometric measurements using ImageJ software and
expressed relative to the optical density (OD) of the β-actin band in the same lane (NTPDase1 protein/β-actin ratio). The NTPDase1/β-actin value obtained for the
control sample was defined as 100% ± SEM and the ratios obtained for other samples were expressed relative to the control (bars). Bars represent the mean
NTPDase1 protein abundance (±SEM) from n ≥ 4 determinations performed on two independent sample preparations. Significance inside the graph: ∗p < 0.05.
(C) Representative support membrane showing the position of bands corresponding to NTPDase1/CD39, visualized on X-Ray films with the use of
chemiluminescence. (D) NTPDase1 immunofluorescence, showing the pattern of immunoreaction at control sections, and sections obtained during EAE. Arrows
indicate the position of infiltrates. Scale bar applicable to all micrographs = 200 µm. (E) Integrated fluorescence densities expressed in arbitrary units (AU),
corresponding to NTPDase1, obtained from control sections and during EAE. Bars represent mean AU ± SEM from n ≥ 6 sections per animal, from 3 animals per
experimental group, from two separate experiments. ∗p < 0.05, ∗∗∗p < 0.0001 in comparison to control. (F) Regions of interest (ROIs) used for quantitative analysis
of NTPDase1-immunofluorescence intensity (DGM, dorsal gray matter; VGM, ventral gray matter; DWM, dorsal white matter; VWM, ventral white matter; LWM,
lateral white matter). (G) Mean integrated fluorescence density of NTPDase1-immunofluorescence (AU) corresponding to ROIs. Bars represent mean ± SEM from
n ≥ 4 micrographs per ROI per section, from n ≥ 6 sections per animal, from 3 animal per group, from two separate experiments. Significance: ∗p < 0.05,
∗∗p < 0.001 and ∗∗∗p < 0.0001 compared to control. (A,E,G) Kruskal–Wallis with Dunn’s post hoc test, (B) one-way ANOVA with Dunnet’s post hoc test.
slightly increased at Eo and markedly increased at Ep, particularly
at NTPDase1 positive cellular infiltrates and fibrous elements
at Ee. The intensity of the fluorescence signal demonstrated a
significant increase in total NTPDase1 immunoreactivity at Eo
and Ep relative to control (Figure 2E), while determination of
pixel intensities confined within individual regions (Figure 2F),
revealed a significant increase in NTPDase1 immunoreactivity in
dorsal gray matter at Eo, in all regions at Ep, and in dorsal white
matter at Ee (Figure 2G).
Visualizing Cells That Express Entpd1
mRNA During EAE
Identification of the cell types expressing NTPDase1 during EAE
was assessed by in situ hybridization of Entpd1 mRNA, combined
with immunohistochemical counterstaining directed to GFAP
(Figure 3). In control sections under higher magnification,
Entpd1 mRNA was detected in GFAP immunoreactive astrocytes
in the white matter, in small ramified cells distributed throughout
the cross-section, in large motoneurons in the ventral gray
matter, in vascular endothelial cells and in ependymal cells
lining the central canal. At Eo increased staining was observed
at ependymal cells and small number of infiltrated cells. The
staining pattern markedly changed at Ep, when prominent
Entpd1 mRNA labeled numerous ovoid cells resembling activated
microglia, scattered in all areas of the spinal cord. The staining
was also more pronounced in numerous infiltrated mononuclear
cells, motoneurons in ventral gray matter, vascular endothelial
and ependymal cells. At Ee, the overall pattern of Entpd1 mRNA
in situ hybridization was comparable with the control. At all time-
points association of Entpd1 mRNA with GFAP immunoreactive
astrocytes in the gray matter was weak and indistinct.
Expression of NTPDase1 by
Microglia/Macrophages and Astrocytes
Contributions of microglia/macrophages and astrocytes to
the induction of NTPDase1 in lumbar spinal cord during
EAE were evaluated by triple immunofluorescence labelings
directed to NTPDase1, Iba1 as constitutive marker of
microglia/macrophages and GFAP as pan astrocytic marker
(Figure 4). In control sections, NTPDase1 was associated
with highly ramified Iba1 positive cells, that show non-
overlapping pattern of tissue distribution, indicating resting
microglia. At Eo the NTPDase1 immunoreactivity was
located at Iba1 positive perivascular and subpial infiltrates
and parenchymal cells with shortened and thickened processes
and decreased intercellular distances indicating microglial
activation (Figures 4A,B). Ep sections displayed significantly
more double NTPDase1/Iba1 immunoreactive cells compared
to control, mostly with amoeboid morphology indicative of
activated microglia/macrophages and usually observed in
clusters. Double reactive NTPDase1/Iba1 ovoid cells were
often seen in close apposition with GFAP immunoreactive
astrocytes. At Ee, number of Iba1 immunoreactive cells returned
to control level. Majority of Iba1 positive cells acquired ramified
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FIGURE 3 | In situ NTPDase1-mRNA hybridization. In situ hybridization using NTPDase1-specific DIG-labeled oligonucleotide probes in a combination with HRP -
based immunohistohemical staining and GFAP immunohistochemistry. Low-power magnification micrographs show distribution of NTPDase1-mRNA at
cross-sections from control (scale bar applicable to all low-power micrographs = 500 µm), Eo, Ep, and Ee. High-power micrographs are magnified from the areas
enclosed by rectangles at each low-power micrograph. Scale bar at (A) insertion from control section applicable to all insertions = 50 µm. NTPDase1 mRNA
expression is visible in microglia-like cells (indicated by arrowheads) and astrocytes (indicated by arrows) in the white matter (A), large α-motoneurons in ventral
horns of gray matter (B), neurons in dorsal gray matter (C), ependymal cells (D), perivascular infiltrates and vascular endothelial cells (E).
morphology, indicating microglial deactivation. The extent of
colocalization between NTPDase1 and Iba1 immunoreactivity
in the spinal cord cross-sections was assessed by determining
the values of PCC and MCC. The PCC, which reflects both
co-occurrence and correlation between NTPDase1 and Iba1
reactivity, increased significantly from 0.6 in control sections
to almost 0.8, in Ep sections (Figure 4C), indicating significant
overlap between the two fluorescence signals. The co-occurrence
of two signals was expressed also in terms of contribution
of NTPDase1 to the total NTPDase1/Iba1 immunoreactivity
(MCC1), and contribution of Iba1- to the total NTPDase1/Iba1
immunoreactivity (MCC2). MCC1 value increased from 0.4 in
control sections, to 0.8 in Ep sections, and declined to the control
level at Ee. The value of MCC2, which reflects the fraction of Iba1
immunofluorescence colocalized with NTPDase1, did not change
during EAE (Figure 4D). Thus, the variations in MCC1 implied
a significant contribution of reactive microglia and macrophages
to the observed up-regulation of NTPDase1 during EAE,
showing that the prominent increase in fraction of NTPDase1
immunofluorescence colocalized with Iba1 was up to 80%.
In accordance with results obtained by in situ hybridization,
NTPDase1 immunofluorescence was observed in association
with GFAP positive processes mostly in the white matter. The
extent of NTPDase1/GFAP colocalization was determined by
assessing both PCC and MCC. PCC values for NTPDase1/GFAP
co-occurrence accounted for less than 0.4, thus confirming
our microscopic observations that there is only partial
association of the two signals and low basal expression of
NTPDase1 at spinal cord astrocytes. The fractional overlap
between NTPDase1 and GFAP immunofluorescence, expressed
as MCC1 value, decreased from 0.3 in control sections to
0.2 in Ep sections (Figure 4D), implying that reactive
astrocytes did not up-regulate expression of NTPDase1
during EAE. The degree of colocalization for both cell
markers with NTPDase1 was additionally confirmed
with preliminary results obtained by confocal microscopy
(Supplementary Figure 1).
Functional State of NTPDase1 Positive
Microglia/Macrophages
While gene and protein expression analysis revealed a significant
up-regulation of NTPDase1 in spinal cord tissue during
EAE, immunohistochemical and colocalization data pointed
to reactive microglia/macrophages as cells responsible for the
progressive NTPDase1 expression during EAE. Considering that
the resolution of the acute neuroinflammation is associated with
the transition from pro- to antiinflammatory functional state
of microglia/macrophages, it was tempting to speculate that
induction of NTPDase1 by reactive microglia/macrophages may
be part of the program that characterizes the M2-like phenotype.
Therefore, we first assessed the expression profiles of several
factors, that are well-known indicators of immune environment
of the tissue during EAE (Table 3). The expression of target genes
coding for Iba1 (Aif1), inducible nitric oxide synthase (Nos2),
arginase1 (Arg1), CD68 (Cd68), CD11b (Itgam), and fractalkine
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FIGURE 4 | Expression of NTPDase1 by microglia/macrophages and astrocytes. (A,B) Representative micrographs of spinal cord cross-sections from white matter
(wm) and gray matter (gm), respectively, showing triple immunofluorescence labeling directed to NTPDase1 (red fluorescence), Iba1 (green fluorescence) and GFAP
(blue fluorescence). Scale bar applicable to all micrographs = 20 µm. (C) Pearson’s correlation coefficients (PCC), showing level of overlap between
NTPDase1/Iba1-ir (gray bars) and NTPDase1/GFAP-ir (yellow bars) in the white and gray matter of spinal cord cross-sections. Bars represent mean PCC ± SEM
from n ≥ 4 micrographs per section, for n ≥ 6 sections per animal, from 3 animals per experimental group, from two separate experiments. Significance inside the
graph:∗p < 0.01, ∗∗∗p < 0.0001 in comparison to control. (D) Manders’ colocalization coefficients MCC1 and MCC2, showing fractional overlap between pairs of
signals as shown inside the graph, obtained for the whole spinal cord cross-section. Bars represent mean ± SEM from n ≥ 4 micrographs per section, n ≥ 6
sections per animal, from 3 animals per experimental group, from two separate experiments. Significance inside the graph: ∗p < 0.01, ∗∗∗p < 0.0001 in comparison
to control. (C,D) Kruskal–Wallis with Dunn’s post hoc test.
receptor (Cx3cr1) exhibited several-fold increase, that peaked at
Eo for Nos2 and Arg1 and at Ep for all the other analyzed genes.
Next, we performed triple immunofluorescence labeling to
assess the co-occurrence of NTPDase1/Iba1 immunoreactivity
with either iNOS or Arg1, which are selective markers of M1- and
M2 microglial/macrophages state respectively (Figures 5A,B).
In accordance with increased mRNA expression, and observed
increase in the number of Iba1 positive cells in spinal cord
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TABLE 3 | Expression profiles for selected cellular markers of immune function.
Target gene Target gene/GAPDH-mRNA (fold change in
respect to control)
Eo Ep Ee
Aif1 5.2 ± 0.5∗∗ 14.5 ± 0.5∗∗∗ 4.5 ± 0.4∗
Nos2 12079 ± 2590∗∗∗ 1370 ± 389∗∗∗ 99 ± 39
Arg1 8.5 ± 0.7∗∗∗ 6.5 ± 1.7∗∗∗ 1.5 ± 0.2
Cd68 29.0 ± 5.4∗∗∗ 67.2 ± 3.8∗∗∗ 16.7 ± 2.4∗
Itgam 11.3 ± 1.2∗∗∗ 11.0 ± 0.6∗∗∗ 3.9 ± 0.3
Cx3cr1 1.2 ± 0.2 4.1 ± 0.8∗∗ 3.1 ± 0.3∗
∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001 in respect to control, Kruskal – Wallis with
Dunn’s post hoc test.
cross- sections, Iba1 immunofluorescence increased about 2-
and 2.5-fold at Eo and Ep (Figure 5C). The overall fluorescence
intensity of iNOS reactivity increased from control to Eo and
Ep and then declined at Ee (Figure 5A), that is in accordance
with the iNOS mRNA expression analysis. Microscopic
observations were additionally confirmed by quantification of
total iNOS immunofluorescence (Figure 5D). At Eo, iNOS
immunofluorescence considerably overlapped with Iba1- and
NTPDase1 reactivity. At Ep, iNOS immunoreactivity was
localized both at NTPDase1-/Iba1 immunoreactive cells, and
at NTPDase1 reactive/Iba1 negative ovoid cells, probably
belonging to infiltrated lymphoid cells. Although the results
of Arg1 expression demonstrated the strongest induction of
Arg1 mRNA at Eo (Table 2), the Arg1- immunoreactivity was
observed mostly at Ep, at a number of amoeboid cells that
co-expressed NTPDase1 and Iba1 (Figure 5B). Accordingly,
total Arg1 immunofluorescence was significantly increased only
at Ep (Figure 5E). The determination of MCC1 coefficient for
Iba1/iNOS co-occurrence at different phases of EAE revealed
that the fraction of Iba1-immunofluorescence colocalized
with iNOS was about 10% at Eo and Ep, while it decreased
to about 5% at Ee (Figure 5F). The MCC1 coefficient for
Iba1/Arg1 immunoflurescence showed insignificant overlap
between two signals at Eo, then about 25% of overlap at Ep
and less than 5% overlap at Ee (Figure 5F). The overlap
of both reactive microglia/macrophages markers with Iba1
fluorescence declined at Ee, which is in accordance with
the resolution of the acute disease. Together, these data
indicate that at Eo, M1-like microglial/macrophages phenotype
prevails, whereas, at Ep, M2-like phenotype prevails. Since
activated microglia/macrophages in vivo may simultaneously
express markers of M1 and M2 activation state, we stained
consecutive sections for Iba1/NTPDase1 and either iNOS
or Arg1. At representative micrographs obtained by overlay
of Iba1/iNOS/NTPDase1 immunofluorescence with Arg1
immunofluorescence (Supplementary Figure 2) approximately
half of Iba1/NTPDase1 positive cells showed coexpression of
FIGURE 5 | The functional state of NTPDase1-positive microglia/macrophages. (A,B) Representative micrographs showing triple immunofluorescence labeling
directed to NTPDase1 (red fluorescence), Iba1 (blue fluorescence) and iNOS or Arg1 (green fluorescence) at cross-sections of lumbar spinal cord white matter in
control and during EAE. Integrated density corresponding to Iba1 (C), iNOS (D), and Arg1 (E) immunofluorescence in control sections, and during EAE. Bars
represent mean fluorescence ± SEM, from n ≥ 4 images per section, n ≥ 6 sections per animal, from 3 animals per experimental group, from two separate
experiments. Significance inside the graph: ∗∗∗p < 0.0001 in comparison control. (F) MCC values obtained from multi-image colocalization analyses of micrographs
presented in (A), showing level of co-occurrence of pair of signals, as indicated inside the graph. ∗∗p < 0.01, ∗∗∗p < 0.0001 in comparison to control. (G) MCC
values calculated for pairs of signals, as indicated inside the graph. Bars at mean MCC value ± SEM from n ≥ 4 images per section, from n ≥ 6 sections per animal,
from 3 animals per experimental group, from two separate experiments. Significance inside the graph: ∗p < 0.05, ∗∗p < 0.001, ∗∗∗p < 0.0001 in comparison to
control. (C–G) Kruskal–Wallis with Dunn’s post hoc test.
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iNOS and Arg1 at Eo, indicating mixed M1/M2 phenotype. At Ep
number of iNOS/Arg1 double-positive cells decreased and only
a small number of such cells per section were visible. At Eo the
majority of cells showed either iNOS or Arg1 immunoreactivity,
while at Ep there were only a few iNOS single positive cells and
much more cells showing Arg1 immunoreactivity, indicating
prevalence of M2-like microglial/macrophages activation state at
the peak of EAE. However, due to overcrowding of infiltrates with
microglia/macrophages, it was hard to distinguish individual
Iba1 positive cells and to determine the number of Iba1 positive
cells that express either iNOS, Arg1 or both markers.
The colocalization coefficients for fractional overlap between
NTPDase1/iNOS and NTPDase1/Arg1 immunoreactivity
confirmed that less than 10% of total NTPDase1 fluorescence
overlapped with iNOS reactivity at Eo and Ep (Figure 5G),
whereas 10 and 30% of NTPDase1fluorescence overlapped with
Arg1 at Eo and Ep, respectively. These data confirm significantly
higher overlap of NTPDase1- and Arg1 immunoreactivity at
Ep, that suggest an association of NTPDase1 with M2-like
microglia/macrophages. The MCC for Arg1/NTPDase1 co-
occurrence implies a significant overlap between Arg1 and
NTPDase1 immunofluorescence of about 65% at Ep.
Expression of NTPDase1 by
Mononuclear Infiltrates
The induction and progression of EAE were associated with
progressive infiltration of peripheral immune cells (Figure 6A),
that were observed in clusters of mononuclear cells, known to
massively invade CNS during EAE. The number of infiltrates
(Figure 6B) and a number of cells per infiltrate (Figure 6C)
were low at Eo, significantly increased at Ep and declined at Ee,
although the infiltrated cells were still apparent at the end of
disease. The extent of cellular infiltrations in the lumbar spinal
cord was evidenced at molecular level, by expression profiling
of integrin αM (CD11b) gene (Itgam) and Cx3cr1, that reflects
the presence of monocytes/macrophages and T cells, but also
microglia, respectively. Eleven-fold increase in Itgam-mRNA and
a fourfold increase in Cx3cr1-mRNA were demonstrated at Ep in
respect to control (Table 3).
The contribution of mononuclear infiltrates to the overall
increase in NTPDase1 expression in EAE was estimated by
flow cytometry (Figures 6D–F). The cells were separated from
the spinal cord tissue by differential centrifugation in Percoll
gradient. The portion of NTPDase1+ cells in total mononuclear
cell fraction increased from about 20% at Eo, to about 70% at
Ep (Figure 6G). The number of mononuclear cells decreased
at Ee (Figures 6A–C), however, the fraction of NTPDase1+
cells as determined by flow cytometry, remained high, at about
60% (Figure 6G).
Since it was already shown that about half of the mononuclear
cell fraction isolated at the peak of EAE represents T cells with
prevalence of CD4+ subset, we assessed the contribution of
CD4+ cells to NTPDase1 expression at the peak of EAE using
flow cytometry (Figures 6H,J). In accordance with literature data,
nearly 45% of mononuclears were CD4+ cells, with more than
70% of NTPDase1+ cells possibly indicating a regulatory subset
of T cells. Our results also show that nearly half of NTPDase1+
mononuclear cell fraction belongs to CD4+ cells subset.
In addition, considering that co-stimulatory receptor CD40
represents a marker of activated microglia/macrophages, we
estimated contribution of CD40+ cells to NTPDase1 expression
in mononuclear fraction at Ep (Figures 6I,J). Our results show
that CD40+ cells represent nearly 25% of total mononuclear
fraction, with about 80% of NTPDase1+ cells. At the peak
of EAE 40% of NTPDase1+ mononuclear cells were CD40+,
indicating activated microglia/macrophages, but also dendritic
cells and lymphocytes.
Finally, since mononuclear cell fraction at the peak of EAE
is mostly comprised of CD45+ cells of haematopoietic origin
including microglia/macrophages, we analyzed contribution of
these cells to NTPDase1 expression at Ep by flow cytometry
(Figures 6K–M). CD45+ cells comprised about 86% of
mononuclear cells fraction, with almost 80% coexpressing
NTPDase1. Also, among NTPDase1+ positive cells about 93%
coexpressed CD45. Additionally, by setting boundaries between
cell populations showing low, intermediate (int) and high
(hi) CD45 expression, we evidenced about 29% of CD45low
(indicating resting microglia), 36% of CD45int (indicating
activated microglia) and 23% of CD45hi (indicating macrophages
and other haematopoietic cells such as dendritic cells or
lymphocytes). NTPDase1 was expressed in about 62% of CD45low
fraction, 87% of CD45int fraction, and 92% of CD45hi fraction.
Functional State of NTPDase1-ir
Reactive Microglia/Macrophages
The association of NTPDase1 with infiltrated
monocytes/macrophages and reactive microglia during
EAE was further assessed at spinal cord cross-sections, by
double immunolabeling for NTPDase1 and CD68 (Figure 7),
which marks the cells with phagocytic activity. The activation
state of double NTPDase1/CD68stained cells was assessed
by third immunofluorescent stain, directed either to iNOS
(Figure 7A) or Arg1 (Figure 7B). As expected, control sections
were completely devoid of CD68 reactivity. At Eo, CD68
immunoreactive cells with typical ovoid morphology appeared
within infiltrates, mostly in subpial and perivascular region.
At Ep, number of CD68 positive cells increased, while at
Ee, only a few CD68-immunoreactive cells per section were
observed. In all time-points, the majority of CD68 positive
cells showed NTPDase1 immunoreactivity. CD68/iNOS double
reactive cells were observed at Eo, while at Ep their number
decreased. Regarding Arg1, only a few double CD68/Arg1 cells
were observed at Eo, while at Ep their number increased. The
micrographs were used for the determination of the MCC
coefficients for co-occurrence between the corresponding
signals. Microscopic observations were confirmed with
calculated MCC1 coefficients for CD68/iNOS and CD68/Arg1
co-occurrence, respectively, indicating that only 5% of the total
CD68 reactivity overlapped with iNOS, whereas almost 50%
overlapped with Arg1 immunofluorescence at Ep (Figure 7C).
Since values of MCC2 for NTPDase1/CD68 co-occurrence
(Figure 7D) indicated that up to 50% of total CD68 fluorescence
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FIGURE 6 | Expression of NTPDase1 by mononuclear cell infiltrates. (A) Low-power micrographs of spinal cord cross-sections stained by Hoechst for cell nuclei.
Arrows indicate position of infiltrates. The scale bar applicable to all micrographs = 200 µm. (B) Infiltrates were counted from Hoechst-stained cross-sections of
lumbar spinal cord at Eo, Ep, and Ee. Bars represent mean number ± SEM, from n ≥ 6 sections per animal, from 3 animals per disease phase, from two
independent experiments. Significance inside the graph: ∗p < 0.05 in respect to Eo. (C) Average number of cells within infiltrates. Bars present mean
number ± SEM, counted from n ≥ 6 sections per animal, from 3 animals for each phase, from two independent experiments. Significance inside the graph:
∗∗∗p < 0.0001 in respect to Eo, ##p < 0.01 in respect to Ee. (D–F) Fractions of mononuclear infiltrates that express NTPDase1 at each phase of EAE were
determined by flow cytometry. Representative dot-plots showing NTPDase1-immunoreactivity of mononuclear cells isolated from lumbar spinal cord. (G) Relative
number of NTPDase1+ cells in mononuclear infiltrates during EAE, as determined by flow cytometry. Bars represent mean fraction (%) ± SEM of total NTPDAse1+
cells, obtained from 3 animals per group, from two independent experiments. Significance inside the graph: ∗∗p < 0.01, ∗∗∗p < 0.001 compared to Eo. (B–G)
Kruskal–Wallis with Dunn’s post hoc test. Representative dot plots from flow cytometric analysis of mononuclear cells fraction at Ep, stained for NTPDase1 and CD4
(H) and for NTPDase1 and CD40 (I). (J) Table represent results of flow cytometric analysis of cells stained for NTPDase1 and either CD4 or CD40, expressed as
mean fraction (%) ± SEM. (K,L) Representative dot plot from flow cytometric analysis of mononuclear cells fraction at Ep, stained for NTPDase1 and CD45, with (L)
showing boundaries between cells with low (R3), intermediate (R4), and high (R5) expression of CD45. (M) Table represent results of flow cytometric analysis of cells
stained for NTPDase1 and CD40, expressed as mean fraction (%) ± SEM. (J,M) are from flow cytometric analysis performed on cells isolated at Ep from 10 animals.
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FIGURE 7 | Functional state of NTPDase1 positive phagocytically active microglia/macrophages. (A,B) Representative micrographs showing triple
immunofluorescence labeling directed to NTPDase1 (red fluorescence), CD68 (blue fluorescence), and iNOS or Arg1 (green fluorescence) at spinal cord
cross-sections obtained from control animals and during EAE. Scale bar applicable to all micrographs = 20 µm. (C,D) MCC values obtained by multi-image
colocalization analysis of micrographs represented in (A,B), showing fractional overlap between pairs of signals, as indicated inside the graph. Bars represent mean
value ± SEM, from n ≥ 4 images per spinal cord region, from n ≥ 6 sections per animal, from 3 animals per experimental group, from two separate experiments.
Significance inside the graph: ∗p < 0.05; ∗∗∗p < 0.0001 in respect to control, Kruskal–Wallis with Dunn’s post hoc test.
overlapped with NTPDase1 at Ep, obtained results indicate
that a significant portion of CD68 immunoreactive cells at
the peak of EAE represent double NTPDase1/CD68 positive
monocytes/macrophages and activated microglia that exhibit
M2-like functional phenotype. In order to determine fractions
of CD68 positive cells that coexpress either one or both
activation state markers, we labeled consecutive sections for
NTPDase1/CD68 and iNOS or Arg1 and counted cells at the
overlayed micrographs (Supplementary Figure 3A). At Eo
we observed a few CD68 positive cells coexpressing iNOS and
Arg1, indicating mixed M1/M2 phenotype and a greater number
of cells expressing only iNOS, indicating M1-like phenotype.
In contrast, at Ep in increased number of CD68 reactive cells
a few cells were iNOS/Arg1 positive while vast number of
cells expressed only Arg1, indicating M2-like phenotype of
microglia/macrophages. Quantification revealed that at Eo
about 50% of CD68 positive cells coexpressed iNOS, while
20% were iNOS/Arg1 positive (Supplementary Figures 3B–E),
indicating prevalence of M1-like phenotype. At Ep, Arg1 was
expressed at 85%, while about 15% of CD68 reactive cells were
iNOS/Arg1 positive, together implying prevalence of M2-like
microglial/macrophages phenotype at the peak of EAE.
Heterogeneity of NTPDase1
Immunoreactive Astrocytes
The preceding in situ hybridization/immunohistochemical study
has demonstrated the presence of Entpd1 mRNA in GFAP
immunoreactive astrocytes mostly in the spinal cord white
matter. Multi-image colocalization analysis has further revealed
that the fraction of NTPDase1immunofluorescence that co-
localizes with GFAP reactivity in spinal cord sections of control
animals amounts to about 30% (Figure 4), and does not vary
during EAE. However, given that GFAP reactivity only partially
overlaps with NTPDase1, we explored the potential astrocyte
heterogeneity based on the presence or absence of NTPDase1.
The sections were double-immunolabeled for NTPDase1
and for either glutamine synthetase (Figure 8A), or vimentin
(Figure 8B). The NTPDase1 fluorescence showed almost a
complete overlap with both glutamine synthetase or vimentin
immunoreactivity mostly in spinal cord white matter. During
EAE, from Eo to Ee, glutamine synthetase positive astrocytes
displayed shortening and thickening of processes and cell body
hypertrophy indicating astrogliosis. Despite prominent labeling
of gliotic astrocytes observed at Ee, Western blot analysis
revealed no significant changes in glutamine synthetase protein
expression (Supplementary Figure 4). Next, we have applied
triple immunofluorescence labeling of NTPDase1/GFAP and
either complement component 3 (Figure 8C) or inducible
cyclooxygenase Cox2 (Figure 8D), which are distinctive
markers of neurotoxic (A1) vs. neuroprotective (A2) astrocytes,
respectively. As expected, the intensity of C3 immunoreactivity
increased during EAE, mostly in infiltrated cells that co-
expressed NTPDase1. With regard to astrocytes, although GFAP
reactivity progressively increased during EAE, C3 fluorescence
was barely seen in association with GFAP positive processes
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FIGURE 8 | Heterogeneity of NTPDase1 positive astrocytes. Representative micrographs showing double immunofluorescence labeling directed to NTPDase1 (red
fluorescence) and (A) glutamine synthetase – GS (B) vimentin, (C) Complement component 3 – C3, and (D) Cox-2 (green fluorescence for all). Sections (A,B) were
counterstained with Hoechst for cell nuclei (blue fluorescence). Sections (C,D) were co-labeled with GFAP (blue fluorescence). Scale bar applicable to all
micrographs = 20 µm.
(Figure 8D). Cox2 immunoreactivity was undetectable in control
sections. During EAE, Cox2 was strongly induced in astrocytes,
while colocalization analysis confirmed increase in fraction of
Cox2 fluorescence overlap with GFAP reactivity from Eo to Ee
and stable overlap with NTPDase1 (Supplementary Figure 5),
particularly in astrocytes in the white matter. The low C3-
and strong Cox2-induction in astrocytes suggest generally low
inflammatory potential of the tissue environment during EAE
in accordance with our published results (Lavrnja et al., 2008,
2012) and suggest induction of beneficial phenotype of reactive
astrocytes. Our preliminary results that show decreased P2Y1
receptor-immunoreactivity at Ep and Ee in fibrous processes in
the white matter, indicating fibrous astrocytes (Supplementary
Figure 6), speak in favor of the induction of the neuroprotective
astrocyte phenotype in our EAE model.
Expression of NTPDase1 by
Neuronal Cells
Considering that in situ hybridization/immunohistochemistry
revealed a subpopulation of large motoneurons in ventral
gray matter expressing Entpd1 mRNA, we further investigated
NTPDase1 expression during EAE in these cells by double
immunofluorescence histochemistry directed to NTPDase1 and
neurofilament heavy subunit NF-H (Figure 9A). In control
sections, NTPDase1immunoreactivity was mostly present at large
motoneurons in ventral gray matter and the overall NTPDase1
fluorescence intensity decreased during EAE. Quantification of
NTPDase1 fluorescence intensity corresponding to individual
neuronal cell bodies in ventral gray matter showed significant
down-regulation evidenced until the end of the disease
(Figure 9B). At Eo and Ep, neuronal cell bodies were seen in close
apposition with NTPDase1-positive ovoid cells.
DISCUSSION
The aim of the present study was to identify cell types that
are responsible for massive up-regulation of NTPDase1 in the
spinal cord of animals affected by EAE, and the potential
pathophysiological significance of such changes. Briefly, the
expression of Entpd1 mRNA and NTPDase1 protein increased
with the onset of symptoms, and reached a maximum at the
peak of the disease, being about 3- and 2-fold higher than
in control, respectively. At the end of the disease, NTPDase1
mRNA and protein expression returned to the control levels.
In situ hybridization and immunofluorescence labeling of
NTPDase1, combined with a second label directed toward the
selective cellular markers of neurons, microglia/macrophages
or astrocytes, were used to establish the cellular contribution
of strongly enhanced NTPDase1 during EAE. In accordance
with the existing literature data (Braun et al., 2000), in control
animals, NTPDase1 mostly resided at ramified microglia and
vascular endothelium, while prominent labeling was found at
large neuronal cell bodies in the ventral gray matter, and
at fibrous astrocytes in the white matter. However, during
EAE, activated microglia and mononuclear infiltrates accounted
for most of the enhanced NTPDase1 expression, whereas the
expression levels of NTPDase1 even slightly decreased at neurons
and astrocytes. Given that reactive microglia/macrophages and
astrocytes are beside CD4+T cells the most important effectors of
neuroinflammation during EAE (Murphy et al., 2010; Brambilla
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FIGURE 9 | Expression of NTPDase1 by neuronal cells. (A) Representative micrographs showing double immunofluorescence labeling of spinal cord gray matter,
with antibodies directed to NTPDase1 (red fluorescence) and neurofilament heavy subunit (NF-H) (green fluorescence). Arrows indicate microglial-like cells in close
apposition with large motoneuron cell body. Scale bar applicable to all micrographs = 20 µm. (B) Integrated fluorescence density corresponding to NTPDase1
reactivity associated with large motoneuron cell body. The intensity was determined as signal confined within an outline of motoneuron cell body, from at least 3
neurons per section, from n ≥ 6 sections per animal, from 3 animals per experimental group. Significance inside the graph: ∗p < 0.01, ∗∗p < 0.001, and
∗∗∗p < 0.0001, one – way ANOVA with Dunnet’s post hoc test.
et al., 2014), we next assessed individual contribution of each
of these cell types to observed increase in NTPDase1 expression
along with the functional state of these cells during EAE.
Double-immunofluorescence labeling and co-localization
analysis revealed that in control sections, about 40% of total
NTPDase1 immunoreactivity resides at Iba1-positive cells, while
up to 80% of Iba1 immunoreactivity overlapped with NTPDase1
fluorescence, which is in accordance with our microscopic
observations and literature data (Braun et al., 2000) on
constitutive expression of NTPDase1 by quiescent microglia.
The abundance of Iba1, which tags microglia/macrophages
irrespective of their functional state, increased several-fold during
EAE, reaching the maximum at Ep, due to the increased
number of activated microglial cells and macrophages attracted
by neuroinflammation. However, despite strong Iba1 up-
regulation, the fractional overlap between Iba1- and NTPDase1-
immunofluorescence remained steadily at 80%. Such high
degree of fractional overlap point to microglia/macrophages
as cells accountable for the most of the enhanced NTPDase1
expression during EAE. These results are in compliance with
previously reported up-regulation of NTPDase1 at microglia
in neuroinflammatory conditions induced by traumatic brain
injury (Nedeljkovic et al., 2006; Simon et al., 2017). Furthermore,
stable high levels of Iba1/NTPDase1 co-occurrence confirmed
our observations that NTPDase1 is expressed by the vast majority
of microglia/macrophages, irrespective of their activation state.
We evidenced a massive infiltration of mononuclear cells
in the spinal cord tissue at Ep using immunohistochemistry
and by detecting several-fold induction of Itgam and Cx3cr1
mRNA (Sunnemark et al., 2005; Greter et al., 2015). The
contribution of infiltrated mononuclear cells to the observed up-
regulation of NTPDase1 was assessed by flow cytometry. The
fraction of infiltrated NTPDase+ cells in general mononuclear
population increased from about 20% at Eo, to about 80% at
Ep. It was previously shown that microglia and macrophages
account for 12% of mononuclear fraction isolated from spinal
cord at the peak of disease, while T cells constitute about
40% (White et al., 1998), out of which the majority are
CD4+ subset that is crucial in neuroinflammation during
EAE (Dittel, 2008; Murphy et al., 2010; Constantinescu et al.,
2011). In accordance with previously reported data from the
same EAE model (Miljkovic et al., 2011), in mononuclear
fraction isolated from the spinal cord at the peak of EAE was
evidenced almost 45% of CD4+ cells, mostly comprising T
lymphocytes. About 70% of these cells were NTPDase1/CD39+,
possibly indicating regulatory subset (Borsellino et al., 2007).
This means that at Ep about 30% of mononuclear fraction,
otherwise maximal at that time-point, probably belongs to
Tregs subset. It was previously shown that Tregs crucially
contribute to spontaneous resolution of neuroinflammation in
EAE/MS (Kleinewietfeld and Hafler, 2014; Koutrolos et al.,
2014; Wang et al., 2014). Additionally, constitutive expression
of both NTPDase1/CD39 and e-5NT/CD73 was reported in
murine Tregs (Borsellino et al., 2007; Deaglio et al., 2007).
Considering our results, through secretion of antiinflammatory
cytokines (Koutrolos et al., 2014) and ATP removal coupled
with adenosine production (Deaglio et al., 2007), Tregs might
sustain antiinflammatory transition of microglia/macrophages at
the peak of neuroinflammation.
It was previously shown that co-stimulatory receptor CD40,
which is critical for reactivation of autoaggressive T cells
(Becher et al., 2001), has a key role in neuroinflammation
(Aarts et al., 2019). Additionally, it was reported that CD40
was expressed in approximately 45% of activated microglia and
73% of macrophages in mononuclear cells fraction at the peak
of EAE (Aarts et al., 2017). Accordingly, our results showed
that nearly 30% of isolated mononuclears at Ep were CD40+
cells, out of which 82% coexpressed NTPDase1. Although in
microglia/macrophages CD40 is regarded as M1 marker (Aarts
et al., 2017), it was evidenced that about 70% of CD40 positive
microglia/macrophages in MS lesions coexpress markers of M2
phenotype, indicating frequent CD40 association with mixed
M1/M2 phenotype (Vogel et al., 2013). This also suggests that
at least part of CD40/NTPDase1 positive microglia/macrophages
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evidenced at Ep in our EAE model may exhibit some form of
intermediary M1/M2 phenotype.
In accordance with literature data (White et al., 1998)
mononuclear fraction isolated at the peak of EAE comprised
nearly 87% of CD45+ cells, indicating both blood-borne cells
and resident microglial cells, abundantly expressing NTPDase1.
On the basis of relative CD45 expression (Zhang et al.,
2002; Rumble et al., 2015) we evidenced about 29% of
CD45 low-expressing cells, indicative of resting microglia,
36% of intermediary-expressing indicating mostly activated
microglia and 24% of CD45 high-expressing mononuclear
cells comprising macrophages and other heamatopoetic cells,
mostly in compliance with literature data (Miljkovic et al.,
2011; Rumble et al., 2015; Stojic´-Vukanic´ et al., 2016).
Increase in fraction of CD45/NTPDase1 positive cells from
low- to high expressing CD45+ cells imply that activation
induced by neuroinflammation enhances NTPDase1 expression
in microglia/macrophages and also indicates largest contribution
of activated microglia to increase in total NTPDase1 expression
in spinal cord at the peak of EAE.
We also determined the expression of NTPDase1 at a
subpopulation of phagocytic cells, which were identified by
the presence of CD68 antigen. At the onset of EAE, about
10% of -total NTPDase1-immunoreactivity resided at CD68
positive cells. The expression of CD68 increased several-
fold during EAE, apparently due to an increased number of
phagocytic microglia/macrophages (Supplementary Figure 3B)
in the neuroinflammatory disease (Fu et al., 2014), while
the fraction of NTPDase1 immunofluorescence overlapped
with CD68 reactivity increased to about 30% at Ep. Taken
together, our findings suggest that phagocytically active cells are
accountable for about 30% of increased NTPDase1 expression at
the peak of EAE.
Under neuroinflammatory conditions, quiescent
microglia and peripheral macrophages undergo conspicuous
morphological changes, along which they acquire functional
characteristics of reactive cells (Volonte et al., 2016). The
reactive microglia/macrophages may acquire any phenotype
within the spectrum between two extremes, termed M1 and
M2 (Fumagalli et al., 2015; Kalkman and Feuerbach, 2016;
Parisi et al., 2016; Geloso et al., 2017). It was established
in vitro that classically activated M1 microglia/macrophages,
induced by LPS and IFNγ, exhibit cytotoxic and pro-
inflammatory actions, while alternatively, IL-4 activated
M2 microglia/macrophages, exhibit protective and anti-
inflammatory properties (Porta et al., 2009; Kalkman and
Feuerbach, 2016). Since peripheral macrophages in vitro down-
regulate NTPDase1 during the polarization toward the M1
phenotype (Zanin et al., 2012), we have hypothesized that
the transition from M1 to M2 phenotype in microglia and
infiltrated macrophages during the acute neuroinflammation
in EAE, might be associated with the up-regulation of
NTPDase1 by those cells. Given that the most commonly
used differential markers of M1 and M2 functional states
are iNOS and Arg1, respectively (Cherry et al., 2014),
we applied multi-immunofluorescence labeling to test
this hypothesis.
The acute neuroinflammatory response in EAE was associated
with a biphasic pattern of expression of several reactive microglia
and astrocytic markers, including iNOS and Arg1. Expression
of both reactive markers massively increased already at Eo, and
gradually decreased thereafter, returning to the control level at Ee.
On the other hand, iNOS immunoreactivity was increased at the
onset and peak, while Arg1 fluorescence was most prominently
upregulated at the peak of EAE. However, while the highest
overlap between Iba1- and iNOS-immunoreactivity occurred at
Eo, the highest overlap between Iba1/Arg1-immunoreactivity
occurred at Ep, suggesting a prevalence of M1-like reactive
microglia/macrophages at the onset and the M2-like phenotype at
the peak of EAE. Additionally, in accordance with literature data
showing that activated microglia/macrophages in vivo frequently
express mixed markers of M1 and M2 phenotype (Fumagalli
et al., 2015; Kalkman and Feuerbach, 2016), we observed double
iNOS/Arg1 reactivity in one part of Iba1 positive cells at Eo,
and much less at Ep. Prevalence of iNOS positive cells at Eo
and Arg1 positive cells at Ep over double iNOS/Arg1 reactive
microglia/macrophages additionally indicates transition to M2-
like phenotype at the peak of neuroinflammation. Similarly
to Iba1/iNOS and Iba1/Arg1 co-occurence, about 10% of
NTPDase1-fluorescence overlapped with iNOS-reactivity at Eo,
while the highest co-occurrence of NTPDase1- with Arg1-
reactivity of about 30% was found at Ep, again suggesting a higher
association of NTPDase1 with M2-like microglia/macrophages.
In a similar fashion, analysis of iNOS and Arg1 expression
in the phagocytically active cells expressing CD68, revealed the
transition from the M1-like state at Eo to prevalent M2-like state
in Ep. Namely, colocalization analysis revealed about two-fold
higher colocalization of CD68 immunofluorescence with iNOS
compared to Arg1 reactivity at the onset, while at the peak
about half of otherwise increased CD68 immunofluorescence
colocalized with Arg1 as opposed to almost negligible
colocalization with iNOS.
Regarding cellular expression, at the onset iNOS expressing
CD68 positive cells, indicating M1-like activation state,
prevailed over cells exhibiting mixed phenotype, while at
the peak, Arg1-expressing cells were prevalent, additionally
confirming transition to antiinflammatory activation state in
microglia/macrophages at the peak of EAE.
Apart from T and B lymphocytes, microglia and macrophages
are the predominant immune cell types in inflammatory
demyelinating lesions in MS/EAE (Lassmann, 2018) and their
functional phenotype directs the course of neuroinflammation
toward progression or resolution. The transition between
the reactive states is associated with a transcriptional shift
in several thousand genes, including the genes coding the
enzymes involved in arginine metabolism (Xu et al., 2003).
Namely, the M1 vs. M2 microglia/macrophage classification
can be condensed into two opposing pathways for arginine
metabolism, mediated via iNOS or via Arg1, respectively.
Both enzymes compete for L-arginine and metabolize it
to NO and citrulline or ornithine and urea, with opposite
effects regarding neuroinflammation (Morris, 2007; Fenn
et al., 2014). The M1/M2 transition is associated with
a significant shift in cytokine production (Franco and
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Fernandez-Suarez, 2015), which was also reported in our
previous papers (Lavrnja et al., 2008, 2012), that directs
T lymphocytes to produce Th1 or Th2 responses, that
further amplify M1 or M2 type responses in positive
feedback loops stabilizing the predominant immune
phenotype.
In our study, the transition of microglia/macrophages from
M1- to M2-like reactive state occurred at Ep in a significant
fraction of about 80% of otherwise significantly enhanced
activated cells, evidenced at the peak of symptoms, the majority
of which co-expressed NTPDase1. Thus, our results indicate
a strong association of NTPDase1 with antiinflammatory
microglial phenotype and potentiation of its immunosuppressive
effects (Pesce et al., 2009).
Another functional consequence of prevalent M2-like
microglia/macrophage state at Ep may be the influence
on functional state of astrocytes, since reactive microglia
acts as the major inducer of reactive astrocyte phenotype
in neuroinflammatory conditions (Liddelow et al., 2017).
Thus, prevailing antiinflammatory microglial/macophages
phenotype may propel reactive astrocytes toward the beneficial,
neurotrophic phenotype. Also, enhanced expression of
NTPDase1 by microglia/macrophages demonstrated in our
EAE model, may potentiate development of neuroprotective
phenotype in astrocytes through decreased P2Y1 signaling
(Shinozaki et al., 2017). Additionally, we have previously
evidenced decrease in mRNA and protein expression
of P2Y1 during EAE (Jakovljevic et al., 2017) while our
preliminary results (shown in Supplementary Figure 6)
point to fibrous astrocytes as holders of the observed
changes, implying induction of neuroprotective phenotype
in astrocytes (Shinozaki et al., 2017). It was shown that
reactive neurotrophic A2 astrocytes up-regulate many
factors which support the survival and growth of neurons
(Zamanian et al., 2012; Liddelow et al., 2017). Cyclooxygenase
2 (Cox2) is among highly induced and most specific genes
in beneficial astrocytes phenotype, with strong protective
effects in neuroinflammation (Aïd and Bosetti, 2011). We
have evidenced a prominent induction of Cox2 in astrocytes
during EAE, additionally increasing from the onset toward
the resolution phase. Additionally, Cox2 was distinctively
colocalized with NTPDase1 at astrocytes, particularly in
the white matter, indicating their protective phenotype.
Although results of Western blot analysis did not show
changes in glutamine synthetase protein abundance during
EAE, we observed strong labeling of hypertrophied bodies
and thickened processes of perivascular astrocytes and their
endfeet at Ee, indicating intense glutamate and ammonia
removal at gliovascular unit. The up-regulation of Cox2
may be involved in a modulation of cerebral blood flow by
perivascular astrocytes in response to neuroinflammation
(Font-Nieves et al., 2012; Macvicar and Newman, 2015),
which together with glutamine synthetase may support
the recovery of the blood-brain barrier function in EAE
(Bennett et al., 2010).
What is the physiological significance of NTPDase1
induction by reactive microglia/macrophages during EAE?
It is widely accepted that ATP and adenosine arise in
the extracellular space in response to any type of brain
insult to initiate and direct response of microglia and
astrocytes (Rodrigues et al., 2015). Thus, NTPDase1, 2 and
e-5NT calibrate duration, magnitude, and composition
of the “purinergic halo” surrounding the resident glial
and infiltrated immune cells. We have already reported
dynamic changes in the expression and activity of NTPDase2
and e-5NT by reactive astrocytes, and the expression of
the whole set of P1 and P2 receptors embedded in the
pathophysiological context associated with EAE (Lavrnja
et al., 2009, 2015; Jakovljevic et al., 2017). Briefly, the acute
course of EAE is associated with a significant decrease in
ADP-producing NTPDase2 activity and strong attenuation
of ADP-sensitive P2Y1, P2Y12, and P2Y13 signaling at the
peak of disease (Jakovljevic et al., 2017). On the other
hand, the resolution of the acute neuroinflammation in
EAE is associated with massive induction of NTPDase1
[(Jakovljevic et al., 2017), present paper] and e-5NT (Lavrnja
et al., 2015), and attenuation of P2X and potentiation of A2A
and A2B receptor signaling (Lavrnja et al., 2015; Jakovljevic
et al., 2017). NTPDase1 and e-5NT, strongly induced in
EAE by reactive microglia/macrophages and astrocytes,
respectively, expedite degradation of pro-inflammatory ATP
and production of anti-inflammatory adenosine, which is
known to modulate the course and dictate the outcome of
several neuroinflammatory conditions (Gomes et al., 2011),
including EAE. Given that NTPDase1/e-5NT tandem is
able to effectuate the whole sequence of extracellular ATP
degradation, they may be viewed as an “immunological
switch” that shifts pro-inflammatory immune cell activity
toward the anti-inflammatory state (Antonioli et al., 2013).
Therefore, by regulating ATP/adenosine ratio in the extracellular
space, NTPDase1/e-5NT axis participates in the fine-tuning
of microglial/macrophage and astrocyte differentiation and
activity, as it has been already established for peripheral
macrophages. Specifically, deficiency of NTPDase1 in peripheral
macrophages results in ATP accumulation and their polarization
toward the M1-like phenotype characterized by the release
of proinflammatory cytokines IL-1β, IL-18, IL-6, and TNF-α
(Zanin et al., 2012). Accordingly, the enhanced expression
and activity of both NTPDase1/e-5NT in M2 macrophages
alters ATP/adenosine ratio and inflammatory cytokine release.
Thus, it is likely that highly up-regulated NTPDase1 at the
peak of EAE, represents a contribution to or reflection of
enhanced production of adenosine, and transition from
M1- to M2-like microglia/macrophages phenotype. Since
in human MS, M2 microglial/macrophages polarization
arises from Th2 immune responses, and it further influences
the balance between Th1/Th17 and Treg cells, there has
been a strong rationale for therapies in MS that favor M2
differentiation (Liu et al., 2013). Our study provides new
data regarding the involvement of ectonucleotidases in
molecular events underlying the development of M2-like
microglia/macrophages phenotype, which may represent the
basis for M2 potentiating therapeutic strategies based on a
modulation of purinergic signaling.
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